Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00268099 · ClinicalTrials.gov registry record
Optimal Timing for Repair of Right-to-Left Shunt Lesions
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 75
- Enrollment target
NCT00268099: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00268099 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00268099 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 75 participants
- Enrollment target
Study Summary
The primary aim of this study is to determine the optimal timing for repair of right-to-left shunt lesions such as Tetralogy of Fallot defects. The secondary aim being define the criteria for failing medical therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2005-05 |
| Est. Completion | 2006-11 |
Why NCT00268099 stopped before completion
NCT00268099 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00268099 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00268099 about?
NCT00268099 is a clinical study titled "Optimal Timing for Repair of Right-to-Left Shunt Lesions". The primary aim of this study is to determine the optimal timing for repair of right-to-left shunt lesions such as Tetralogy of Fallot defects. The secondary aim being define the criteria for failing medical therapy.
What is the current status of trial NCT00268099?
This trial is currently terminated. The enrollment target is 75 participants. The study started on 2005-05. Estimated completion is 2006-11.
Who is sponsoring clinical trial NCT00268099?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia